AHA

This channel contains news about the American Heart Association (AHA), including coverage of its annual meeting and guidelines. AHA is a leading resource for cardiology information, both consumer and professional.  

Societies Issue Guide to Safely Resume Cardiovascular Procedures, Diagnostic Tests. #COVID19 #SARScov2
Feature | Cardiovascular Business | June 03, 2020
The American College of Cardiology (ACC) together with other North American cardiovascular societies issued a framework...
WHO Database Shows Serious Health Impact of Hydroxychloroquine and Azithromycin Being Used to Treat COVID-19. #COVID19 #SARScov2 #Hydroxychloroquine
Feature | Coronavirus (COVID-19) | May 27, 2020
May 27, 2020 — Two of the front-line drugs being used to treat COVID-19 (SARS-CoV-2) patients are hydroxychloroquine...
Caution Recommended in use of COVID-19 Therapy Using Hydroxychloroquine and Azithromycin in Cardiovascular Disease Patients
Feature | Coronavirus (COVID-19) | April 08, 2020
April 8, 2020 – The scientific community is learning more about the impact and interaction of cardiovascular diseases...
AHA, ACC, HRS, SCAI and other medical societies call for federal government to do what is needed to get medical supplies to front-line clinicians fighting COVID-19. #COVID19 #SARScov2 #Coronavirus
News | Coronavirus (COVID-19) | March 30, 2020
March 30, 2020 — A group of 13 U.S. medical societies sent an open letter to Congress appealing to them to do what is...
 Christie Ballantyne

Dr. Christie Ballantyne, professor of medicine and chief of the section of cardiology at Baylor College of Medicine

News | Pharmaceuticals | December 30, 2019
December 30, 2019 — A drug therapy targeting the production of a protein produced by the liver has led to sustained and...
The most popular content in the month of November on DAIC was by far the data from the late-breaking trials from the American Herart Association (AHA) 2019 meeting. The second item on this month's list is an overview of key heart failure takeaways from AHA by Nasrien Ibrahim, M.D., associate director of resynchronization and advanced cardiac therapeutics at Massachusetts General Hospital.  Photo by Scott Morgan/AHA.

The most popular content in the month of November on DAIC was by far the data from the late-breaking trials from the American Herart Association (AHA) 2019 meeting. The second item on this month's list is an overview of key heart failure takeaways from AHA by Nasrien Ibrahim, M.D., associate director of resynchronization and advanced cardiac therapeutics at Massachusetts General Hospital.  Photo by Scott Morgan/AHA. 

Feature | December 17, 2019
December 16, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC...
ECG
News | AHA | November 22, 2019
November 22, 2019 — Artificial intelligence can examine electrocardiogram (ECG) test results, a common medical test, to...
 EKO digital stethoscopes
News | AHA | November 21, 2019
November 21, 2019 — At the American Heart Association Scientific Sessions 2019, Eko, a digital health company applying...
cardiac arrest cath lab
News | AHA | November 21, 2019
November 21, 2019 — People who experience cardiac arrests over the weekend are less likely to survive long enough to be...
The Cordella Pulmonary Artery Pressure Sensor System for Heart failure. #AHA19 #AHA
News | Heart Failure | November 21, 2019
November 21, 2019 — Endotronix, a digital health and medical technology company dedicated to advancing the treatment of...
John J. V. McMurray presenting the DAPA-HF Trial at AHA 2019. It was part of the late-breaking presentations in the "Outside the Box: New Approaches to CVD Risk Reduction" session.

John J. V. McMurray presenting the DAPA-HF Trial at AHA 2019. It was part of the late-breaking presentations in the "Outside the Box: New Approaches to CVD Risk Reduction" session. Photo by AHA/Phil McCarten

Blog | Heart Failure | November 21, 2019
It’s an exciting time in the heart failure (HF) world right now with the emergence of new therapies, including...
heart disease
News | AHA | November 20, 2019
November 20, 2019 — Heart attack survivors may have an increased risk of developing cancer compared to people without...
 Assorted pastries
News | AHA | November 20, 2019
November 20, 2019 — Ultra-processed foods, which account for more than half of an average American’s daily calories,...
marijuana leaf
News | AHA | November 20, 2019
November 20, 2019 — Frequent cannabis (marijuana) use among young people was linked to an increased risk of stroke, and...
In the ISCHEMIA study, patients were randomized into one of two groups: a conservative strategy or an invasive strategy. Illustration by NYU Langone staff

In the ISCHEMIA study, patients were randomized into one of two groups: a conservative strategy or an invasive strategy. Illustration by NYU Langone staff 

Feature | AHA | November 19, 2019
November 19, 2019 — After 12 years of collecting data, the results of the landmark ISCHEMIA (International Study of...